Louise Proulx
Independent Dir/Board Member bei 9342-8530 QUÉBEC INC.
Profil
Louise Proulx is the founder of Therillia Development Co., Inc. She currently holds multiple positions including Chairman at Univalor, Inc., Chairman at Immune Biosolutions, Inc., Director at 9342-8530 Québec, Inc., Director at BioQuebec, Director at Quebec Blue Cross, Director at Canada Foundation for Innovation, Director-Human Resources at Tekna Plasma Systems, Inc., Director at Consortium Québécois sur la Découverte du Médicament, Director at Diazon Pharmaceuticals, Inc., and Vice President-Research & Development at Canada Armed Forces.
Previously, she served as Chairman at Gestion Univalor LP from 2015 to 2020.
She also held positions as Director at Gemin X Pharmaceuticals US, Inc., Director at McGill University Health Center, Director at Génome Québec, Inc., Director at National Research Council of Canada, Independent Director at Celyad Oncology SA, Director at Verlyx Pharma, Inc., Vice President-Therapeutic Product Development at Biochem Pharma, Inc. from 1985 to 2001, Vice Principal-Research at McGill University from 2002 to 2004, Vice President-Product Development at Topigen Pharmaceuticals, Inc. in 2006, Vice President-Product Development at ViroChem Pharma, Inc. from 2006 to 2009, and Vice President-Scientific Affairs at Hoechst Marion Roussel Canada, Inc. from 1985 to 2001.
She obtained a doctorate degree from Université Laval.
Aktive Positionen von Louise Proulx
| Unternehmen | Position | Beginn |
|---|---|---|
| 9342-8530 QUÉBEC INC. | Independent Dir/Board Member | 16.03.2006 |
Univalor, Inc.
 Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Chairman | 07.02.2012 |
Immune Biosolutions, Inc.
 Immune Biosolutions, Inc. BiotechnologyHealth Technology Immune Biosolutions, Inc. develops polyclonal, recombinant chicken antibodies, diagnostic tools, nutraceuticals and antibody based drugs to explore and resolve health issues. The firm’s products include light speed, sunrise, sunshine-in-a-box, eclipse blocking reagents and aurora detection reagents. The company was founded by Frédéric Leduc, Simon Gaudreau and Jean-François Larrivée in 2012 and is headquartered in Sherbrooke, Canada. | Chairman | - |
Diazon Pharmaceuticals, Inc.
 Diazon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diazon Pharmaceuticals, Inc. engages in the development of the onco-therapeutic DZ-2384 that targets a proven therapeutic pathway in oncology. The company was founded by Anne Roulston, Gordon Shore and Patrick Harran in 2013 and is headquartered in Montreal, Canada. | Director/Board Member | - |
Consortium Québécois sur la Découverte du Médicament
 Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Director/Board Member | - |
BioQuebec
 BioQuebec BiotechnologyHealth Technology BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun. | Director/Board Member | - |
| Canada Armed Forces | Chief Tech/Sci/R&D Officer | 21.02.2011 |
| Canada Foundation For Innovation | Director/Board Member | 08.09.2009 |
Tekna Plasma Systems, Inc.
 Tekna Plasma Systems, Inc. Chemicals: SpecialtyProcess Industries Tekna Plasma Systems, Inc. develops, designs and constructs integrated plasma systems. It offers nanoparticle synthesis, coating applications, and powder plasma treatments such as spheroidization and purification for laboratory research and industrial-scale processes. The firm provides spheroidization, nanopowder, deposition and aerospace equipment, nano and spherical powders, powder treatment and logistic options. The company was founded by Maher I. Boulos and Jerzy W. Jurewicz in 1990 and is headquartered in Sherbrooke, Canada. | Human Resources Officer | - |
| ░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Ehemalige bekannte Positionen von Louise Proulx
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Louise Proulx
| Université Laval | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| 9342-8530 QUÉBEC INC. | Health Technology |
| CELYAD ONCOLOGY SA | Health Technology |
| Private Unternehmen | 21 |
|---|---|
Biochem Pharma, Inc.
 Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Health Technology |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
Topigen Pharmaceuticals, Inc.
 Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Topigen Pharmaceuticals, Inc. develops drugs for respiratory diseases. The firm focuses on discovery and development of multiple pathway therapies for respiratory diseases with primary emphasis on asthma, chronic obstructive pulmonary disease, and allergic rhinitis. The company was founded by Paolo Renzi in 2000 and is headquartered in Montréal, Canada. | Health Technology |
ViroChem Pharma, Inc.
 ViroChem Pharma, Inc. Pharmaceuticals: MajorHealth Technology ViroChem Pharma, Inc. provides antiviral drug research and development services. The company provides R&D services on HIV/AIDS and hepatitis C. It was founded on April 8, 2004 and is headquartered in Laval, Canada. | Health Technology |
BioQuebec
BioQuebec BiotechnologyHealth Technology BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun. | Health Technology |
McGill University Health Center
 McGill University Health Center Hospital/Nursing ManagementHealth Services McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada. | Health Services |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Quebec Blue Cross
 Quebec Blue Cross Multi-Line InsuranceFinance Quebec Blue Cross operates a not-for-profit organization. It offers travel and health insurance products. The company was founded in 1934 and is headquartered in Montreal, Canada. | Finance |
Gestion Univalor LP
 Gestion Univalor LP Miscellaneous Commercial ServicesCommercial Services Gestion Univalor LP Provides research services. Its services include researcher services, and industry and investors services. The company was founded in 2001 and is headquartered in Montreal, Canada. | Commercial Services |
| Canada Armed Forces | Government |
| Canada Foundation For Innovation | Miscellaneous |
National Research Council of Canada
 National Research Council of Canada Miscellaneous Commercial ServicesCommercial Services National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON. | Commercial Services |
Univalor, Inc.
Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Commercial Services |
| Hoechst Marion Roussel Canada, Inc. | |
Tekna Plasma Systems, Inc.
Tekna Plasma Systems, Inc. Chemicals: SpecialtyProcess Industries Tekna Plasma Systems, Inc. develops, designs and constructs integrated plasma systems. It offers nanoparticle synthesis, coating applications, and powder plasma treatments such as spheroidization and purification for laboratory research and industrial-scale processes. The firm provides spheroidization, nanopowder, deposition and aerospace equipment, nano and spherical powders, powder treatment and logistic options. The company was founded by Maher I. Boulos and Jerzy W. Jurewicz in 1990 and is headquartered in Sherbrooke, Canada. | Process Industries |
Verlyx Pharma, Inc.
 Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
Therillia Development Co., Inc.
 Therillia Development Co., Inc. Pharmaceuticals: MajorHealth Technology Therillia Development Co., Inc. operates as a portfolio company of Sanderling Ventures. It develops novel drug candidates of interest to Sanderling and other venture capital investors from preclinical to clinical proof of concept. The company is headquartered in Montreal, Canada. | Health Technology |
Vertex Pharmaceuticals (Canada), Inc.
 Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada. | Commercial Services |
Consortium Québécois sur la Découverte du Médicament
Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Commercial Services |
Immune Biosolutions, Inc.
Immune Biosolutions, Inc. BiotechnologyHealth Technology Immune Biosolutions, Inc. develops polyclonal, recombinant chicken antibodies, diagnostic tools, nutraceuticals and antibody based drugs to explore and resolve health issues. The firm’s products include light speed, sunrise, sunshine-in-a-box, eclipse blocking reagents and aurora detection reagents. The company was founded by Frédéric Leduc, Simon Gaudreau and Jean-François Larrivée in 2012 and is headquartered in Sherbrooke, Canada. | Health Technology |
Diazon Pharmaceuticals, Inc.
Diazon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diazon Pharmaceuticals, Inc. engages in the development of the onco-therapeutic DZ-2384 that targets a proven therapeutic pathway in oncology. The company was founded by Anne Roulston, Gordon Shore and Patrick Harran in 2013 and is headquartered in Montreal, Canada. | Health Technology |
